ATOM Consortium Webinar Series Presents: An Alternative Approach and Business Model to Accelerate Drug Discovery
Cancer researchers and professionals involved in drug discovery are invited to join the Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium’s first webinar in a new series of webinars. ATOM integrates high performance computing, diverse biological data, and emerging biotechnologies to create a platform to reduce the drug discovery timeline.
Dr. John Baldoni, CEO of ATOM Research Alliance, will talk about the ATOM Modeling Pipeline (AMPL), an open-source data-driven modeling pipeline that supports machine learning and molecular featurization tools.
In Dr. John Baldoni’s 41 years in the pharmaceutical industry, he has led organizations spanning drug discovery, preclinical development, manufacturing, and technology development. He is a proponent of seeking, integrating, and implementing innovative approaches to drug discovery and development. John worked with public sector and government partners to form the ATOM Consortium and to create the non-profit ARA. In addition to his work with ARA, he works with cutting edge technology companies to translate innovation to value.
- NIH/NCI Virtual Workshop: Shaping the Landscape of Brain Metastases ResearchSeptember 29, 2022 - September 30, 2022